Viewing Study NCT07007793


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-02-21 @ 5:18 PM
Study NCT ID: NCT07007793
Status: RECRUITING
Last Update Posted: 2025-10-10
First Post: 2025-05-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module